Allergan, Others Look To Ice Apotex Monopoly Suit

Law360, New York (May 25, 2012, 8:18 PM EDT) -- Allergan Inc. and two Japanese drug makers urged a Delaware federal court Thursday to pause Apotex Inc.'s monopolization suit over Allergan's decision to market a new formulation of Zymar until an underlying patent dispute between the companies over the eye infection medication is resolved.

In addition to asking the court to stay the suit, the defendants also lodged two separate motions to dismiss all or part of Apotex's claims, which accuse Allergan of stifling competition by trying to move the market to the new formulation of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.